메뉴 건너뛰기




Volumn 13, Issue 1, 2009, Pages 49-55

Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease

Author keywords

Bone turnover; Hemodialysis; Intact parathyroid hormone; Osteoprotegerin; Soluble receptor activator of nuclear factor B ligand

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE;

EID: 62149103262     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00653.x     Document Type: Article
Times cited : (12)

References (32)
  • 1
    • 0032540319 scopus 로고    scopus 로고
    • Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
    • Lacey DL, Timms E, Tan HL et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998 93 : 165 76.
    • (1998) Cell , vol.93 , pp. 165-76
    • Lacey, D.L.1    Timms, E.2    Tan, H.L.3
  • 2
    • 13044316551 scopus 로고    scopus 로고
    • Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
    • Hsu H, Lacey DL, Dunstan CR et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999 96 : 3540 5.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 3540-5
    • Hsu, H.1    Lacey, D.L.2    Dunstan, C.R.3
  • 3
    • 0033984313 scopus 로고    scopus 로고
    • The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
    • Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000 15 : 2 12.
    • (2000) J Bone Miner Res , vol.15 , pp. 2-12
    • Hofbauer, L.C.1    Khosla, S.2    Dunstan, C.R.3    Lacey, D.L.4    Boyle, W.J.5    Riggs, B.L.6
  • 4
    • 0031735152 scopus 로고    scopus 로고
    • Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
    • Horwood NJ, Elliott J, Martin TJ, Gillespie MT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 1998 139 : 4743 6.
    • (1998) Endocrinology , vol.139 , pp. 4743-6
    • Horwood, N.J.1    Elliott, J.2    Martin, T.J.3    Gillespie, M.T.4
  • 5
    • 0033305046 scopus 로고    scopus 로고
    • Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation
    • Lee SK, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 1999 140 : 3552 61.
    • (1999) Endocrinology , vol.140 , pp. 3552-61
    • Lee, S.K.1    Lorenzo, J.A.2
  • 6
    • 0037073707 scopus 로고    scopus 로고
    • Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein
    • Fu Q, Jilka RL, Manolagas SC, O'Brien CA. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J Biol Chem 2002 277 : 48868 75.
    • (2002) J Biol Chem , vol.277 , pp. 48868-75
    • Fu, Q.1    Jilka, R.L.2    Manolagas, S.C.3    O'Brien, C.A.4
  • 7
    • 0009660825 scopus 로고    scopus 로고
    • Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
    • Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998 139 : 1329 37.
    • (1998) Endocrinology , vol.139 , pp. 1329-37
    • Yasuda, H.1    Shima, N.2    Nakagawa, N.3
  • 8
    • 0032860576 scopus 로고    scopus 로고
    • A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3
    • Morony S, Capparelli C, Lee R et al. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. J Bone Miner Res 1999 14 : 1478 85.
    • (1999) J Bone Miner Res , vol.14 , pp. 1478-85
    • Morony, S.1    Capparelli, C.2    Lee, R.3
  • 9
    • 0034878897 scopus 로고    scopus 로고
    • Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation
    • Ma YL, Cain RL, Halladay DL et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 2001 142 : 4047 54.
    • (2001) Endocrinology , vol.142 , pp. 4047-54
    • Ma, Y.L.1    Cain, R.L.2    Halladay, D.L.3
  • 10
    • 0034014375 scopus 로고    scopus 로고
    • In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene
    • Onyia JE, Miles RR, Yang X et al. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. J Bone Miner Res 2000 15 : 863 71.
    • (2000) J Bone Miner Res , vol.15 , pp. 863-71
    • Onyia, J.E.1    Miles, R.R.2    Yang, X.3
  • 11
    • 0029118191 scopus 로고
    • Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis
    • Qi Q, Monier-Faugere MC, Geng Z, Malluche HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995 26 : 622 31.
    • (1995) Am J Kidney Dis , vol.26 , pp. 622-31
    • Qi, Q.1    Monier-Faugere, M.C.2    Geng, Z.3    Malluche, H.H.4
  • 12
    • 0028788558 scopus 로고
    • Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
    • Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 1995 26 : 836 44.
    • (1995) Am J Kidney Dis , vol.26 , pp. 836-44
    • Wang, M.1    Hercz, G.2    Sherrard, D.J.3    Maloney, N.A.4    Segre, G.V.5    Pei, Y.6
  • 14
    • 0030469027 scopus 로고    scopus 로고
    • Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis
    • Gerakis A, Hutchison AJ, Apostolou T, Freemont AJ, Billis A. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis. Nephrol Dial Transplant 1996 11 : 2430 8.
    • (1996) Nephrol Dial Transplant , vol.11 , pp. 2430-8
    • Gerakis, A.1    Hutchison, A.J.2    Apostolou, T.3    Freemont, A.J.4    Billis, A.5
  • 15
    • 0010516414 scopus 로고    scopus 로고
    • Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients
    • Coen G, Ballanti P, Bonucci E et al. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 1998 13 : 2294 302.
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 2294-302
    • Coen, G.1    Ballanti, P.2    Bonucci, E.3
  • 16
    • 0038417873 scopus 로고    scopus 로고
    • Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients
    • Bervoets AR, Spasovski GB, Behets GJ et al. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Am J Kidney Dis 2003 41 : 997 1007.
    • (2003) Am J Kidney Dis , vol.41 , pp. 997-1007
    • Bervoets, A.R.1    Spasovski, G.B.2    Behets, G.J.3
  • 17
    • 15044348241 scopus 로고    scopus 로고
    • Increased bone resorption in HD patients: Is it caused by elevated RANKL synthesis?
    • Avbersek-Luznik I, Balon BP, Rus I, Marc J. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol Dial Transplant 2005 20 : 566 70.
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 566-70
    • Avbersek-Luznik, I.1    Balon, B.P.2    Rus, I.3    Marc, J.4
  • 18
    • 0037405048 scopus 로고    scopus 로고
    • Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone
    • Locklin RM, Khosla S, Turner RT, Riggs BL. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 2003 89 : 180 90.
    • (2003) J Cell Biochem , vol.89 , pp. 180-90
    • Locklin, R.M.1    Khosla, S.2    Turner, R.T.3    Riggs, B.L.4
  • 19
    • 0034816224 scopus 로고    scopus 로고
    • Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases
    • Fukagawa M, Kazama JJ, Shigematsu T. Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases. Am J Kidney Dis 2001 38 : S152 155.
    • (2001) Am J Kidney Dis , vol.38
    • Fukagawa, M.1    Kazama, J.J.2    Shigematsu, T.3
  • 20
    • 25144433459 scopus 로고    scopus 로고
    • Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis
    • Gonnelli S, Montagnani A, Caffarelli C et al. Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis. J Endocrinol Invest 2005 28 : 534 9.
    • (2005) J Endocrinol Invest , vol.28 , pp. 534-9
    • Gonnelli, S.1    Montagnani, A.2    Caffarelli, C.3
  • 21
    • 0036185308 scopus 로고    scopus 로고
    • Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure
    • Kazama JJ, Shigematsu T, Yano K et al. Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. Am J Kidney Dis 2002 39 : 525 32.
    • (2002) Am J Kidney Dis , vol.39 , pp. 525-32
    • Kazama, J.J.1    Shigematsu, T.2    Yano, K.3
  • 22
    • 0036798106 scopus 로고    scopus 로고
    • Circulating osteoprotegerin is not removed through haemodialysis membrane
    • Kazama JJ, Kato H, Sato T et al. Circulating osteoprotegerin is not removed through haemodialysis membrane. Nephrol Dial Transplant 2002 17 : 1860 1.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 1860-1
    • Kazama, J.J.1    Kato, H.2    Sato, T.3
  • 23
    • 4243068540 scopus 로고    scopus 로고
    • Increased serum osteoprotegerin level in older and diabetic hemodialysis patients
    • Doi S, Yorioka N, Masaki T, Ito T, Shigemoto K, Harada S. Increased serum osteoprotegerin level in older and diabetic hemodialysis patients. Ther Apher Dial 2004 8 : 335 9.
    • (2004) Ther Apher Dial , vol.8 , pp. 335-9
    • Doi, S.1    Yorioka, N.2    Masaki, T.3    Ito, T.4    Shigemoto, K.5    Harada, S.6
  • 24
    • 0034919010 scopus 로고    scopus 로고
    • Osteoprotegerin serum levels in men: Correlation with age, estrogen, and testosterone status
    • Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD. Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 2001 86 : 3162 5.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 3162-5
    • Szulc, P.1    Hofbauer, L.C.2    Heufelder, A.E.3    Roth, S.4    Delmas, P.D.5
  • 25
    • 0036415142 scopus 로고    scopus 로고
    • Renal osteodystrophy and secondary hyperparathyroidism
    • Suppl.
    • Fukagawa M, Kazama JJ, Kurokawa K. Renal osteodystrophy and secondary hyperparathyroidism. Nephrol Dial Transplant 2002 17 (Suppl. 10 2 5.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.10 , pp. 2-5
    • Fukagawa, M.1    Kazama, J.J.2    Kurokawa, K.3
  • 26
    • 0031049994 scopus 로고    scopus 로고
    • The parathyroid-bone axis in uremia: New insights into old questions
    • Hory B, Drueke TB. The parathyroid-bone axis in uremia: new insights into old questions. Curr Opin Nephrol Hypertens 1997 6 : 40 8.
    • (1997) Curr Opin Nephrol Hypertens , vol.6 , pp. 40-8
    • Hory, B.1    Drueke, T.B.2
  • 27
    • 0343457952 scopus 로고    scopus 로고
    • The role of cytokines in skeletal remodelling: Possible consequences for renal osteodystrophy
    • Gonzalez EA. The role of cytokines in skeletal remodelling: possible consequences for renal osteodystrophy. Nephrol Dial Transplant 2000 15 : 945 50.
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 945-50
    • Gonzalez, E.A.1
  • 28
    • 0029787994 scopus 로고    scopus 로고
    • Coordinate regulation of PTH/PTHrP receptors by PTH and calcitriol in UMR 106-01 osteoblast-like cells
    • Gonzalez EA, Martin KJ. Coordinate regulation of PTH/PTHrP receptors by PTH and calcitriol in UMR 106-01 osteoblast-like cells. Kidney Int 1996 50 : 63 70.
    • (1996) Kidney Int , vol.50 , pp. 63-70
    • Gonzalez, E.A.1    Martin, K.J.2
  • 29
    • 0032584208 scopus 로고    scopus 로고
    • Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
    • Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998 95 : 3597 602.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 3597-602
    • Yasuda, H.1    Shima, N.2    Nakagawa, N.3
  • 30
    • 0023552589 scopus 로고
    • Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone
    • Galceran T, Martin KJ, Morrissey JJ, Slatopolsky E. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone. Kidney Int 1987 32 : 801 7.
    • (1987) Kidney Int , vol.32 , pp. 801-7
    • Galceran, T.1    Martin, K.J.2    Morrissey, J.J.3    Slatopolsky, E.4
  • 31
    • 0029913985 scopus 로고    scopus 로고
    • PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats
    • Urena P, Ferreira A, Morieux C, Drueke T, de Vernejoul MC. PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transplant 1996 11 : 2008 16.
    • (1996) Nephrol Dial Transplant , vol.11 , pp. 2008-16
    • Urena, P.1    Ferreira, A.2    Morieux, C.3    Drueke, T.4    De Vernejoul, M.C.5
  • 32
    • 0033532191 scopus 로고    scopus 로고
    • Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)- converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival
    • Lum L, Wong BR, Josien R et al. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 1999 274 : 13613 18.
    • (1999) J Biol Chem , vol.274 , pp. 13613-18
    • Lum, L.1    Wong, B.R.2    Josien, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.